poisar

Stocks · News reference

8-K filing — Liminatus Pharma, Inc. (LIMNW)

SEC EDGARAug 18, 2026, 8:06 PMSEC EDGAR

Filed: 2026-08-18 AccNo: 0001104659-26-098335 Size: 285 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
edgar
Observed
Aug 18, 2026, 8:06 PM
Checked
Aug 18, 2026, 8:06 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading